ZTS
Zoetis Inc - Class A
DRUG MANUFACTURERS - SPECIALTY & GENERIC · HEALTHCARE
Zoetis Inc. (ZTS) stands as a premier global leader in animal health, focusing on the innovation and manufacturing of pharmaceuticals and vaccines for livestock and companion animals alike. Leveraging a robust portfolio backed by advanced research, Zoetis addresses the critical demands of animal agr...
$82.11
-7.95% ($7.09)
Volume
10.09M
52W High
$132.49
52W Low
$68.77
Market Cap
$36.86B
Next Earnings Report
Last Reported
Nov 5, 2026 Beat
Actual: $1.75
vs. Consensus: $1.51
Price Chart
EPS History: Consensus vs Actual
Last 10 quartersPrice Movement Around Earnings
Q3 2026
Nov 5, 2026
1-Day:
-3.26%
Q3 2026
Nov 3, 2026
1-Day:
+7.48%
Q2 2026
Aug 6, 2026
1-Day:
-5.97%
5-Day:
-2.48%
Q2 2026
Aug 4, 2026
1-Day:
-2.17%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q3'26 | $2.39B | -0.4% | 70.8% | 36.1% | $591.0M |
| Q2'26 | $2.47B | +0.3% | 72.7% | 38.0% | $691.0M |
| Q1'26 | $2.26B | +1.9% | 71.7% | 36.3% | $601.0M |
| Q4'25 | $2.39B | +3.0% | 68.9% | 34.6% | $603.0M |
| Q3'25 | $2.40B | +0.5% | 70.2% | 39.0% | $721.0M |
| Q2'25 | $2.46B | +4.2% | 72.3% | 40.2% | $718.0M |
| Q1'25 | $2.22B | +1.4% | 70.5% | 38.1% | $631.0M |
| Q4'24 | $2.32B | +4.7% | 68.0% | 33.0% | $581.0M |
Company Information
Symbol
ZTS
Company
Zoetis Inc - Class A
Market Cap
$36.86B
Sector
HEALTHCARE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in DRUG MANUFACTURERS - SPECIALTY & GENERIC
Compare ZTS with competitors
Side-by-side earnings comparison